Drreddys Laboratories | Spese Operative



Operating Expenses Cambiamento Data
ANI Pharmaceuticals USD 196.2M 25.27M 2025-06
Aurora Cannabis CAD 118.24M 66.26M 2025-06
Bayer EUR 10.73B 688M 2025-06
Canopy Growth CAD 94.22M 4.36M 2025-06
Cipla INR 54.32B 687.8M 2025-06
Corcept Therapeutics USD 167.76M 13.96M 2025-06
Drreddys Laboratories INR 68.61B 3.74B 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
Hikma Pharmaceutical USD 1.31B 63M 2024-12
Lonza CHF 3.09B 564M 2024-12
Novartis USD 9.97B 1.02B 2025-06
Pacira USD 170.87M 3.93M 2025-06
Prestige Brands USD 177.77M 30.32M 2025-06
Richter Gedeon HUF 153.02B 2.72B 2024-09
Sun Pharmaceuticals INR 104.14B 1.45B 2025-06
Supernus Pharmaceuticals USD 153.31M 892K 2025-06
Teva Pharmaceutical Industries USD 3.28B 95M 2025-06


Drreddys Laboratories Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.